Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Velagliflozin

From Wikipedia, the free encyclopedia
Medication

Pharmaceutical compound
Velagliflozin
Clinical data
Trade namesSenvelgo
License data
Routes of
administration
By mouth
ATCvet code
Legal status
Legal status
Identifiers
  • 2-[(4-cyclopropylphenyl)methyl]-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzonitrile
CAS Number
PubChemCID
ChemSpider
UNII
Chemical and physical data
FormulaC23H25NO5
Molar mass395.455 g·mol−1
3D model (JSmol)
  • C1CC1C2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C#N
  • InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1
  • Key:SENUNDCNOYAWGN-ZQGJOIPISA-N
  • Key:UWKBFNWQMSGEPG-ZHNCTCHCSA-N

Velagliflozin, sold under the brand nameSenvelgo, is anantidiabetic medication used for the treatment of cats.[2][4][5] Velagliflozin is asodium-glucose cotransporter 2 (SGLT2) inhibitor.[6] It is takenby mouth.[2]

Medical uses

[edit]

Velagliflozin isindicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.[2][4][6]

References

[edit]
  1. ^"Notice: Multiple additions to the Prescription Drug List (PDL) [2024-10-18]".Health Canada. 18 October 2024. Retrieved25 October 2024.
  2. ^abcd"Senvelgo- velagliflozin solution".DailyMed. 8 November 2023. Retrieved13 December 2023.
  3. ^"Senvelgo Product information".Union Register of veterinary medicinal products. 22 November 2023. Retrieved29 August 2024.
  4. ^ab"NADA 141-568 Senvelgo (velagliflozin oral solution) Cats".Public Domain This article incorporates text from this source, which is in thepublic domain.
  5. ^Cook AK, Behrend E (January 2025)."SGLT2 inhibitor use in the management of feline diabetes mellitus".Journal of Veterinary Pharmacology and Therapeutics. 48 Suppl 1 (Suppl 1):19–30.doi:10.1111/jvp.13466.PMC 11736986.PMID 38954371.
  6. ^ab"Dear Veterinarian Letter regarding important safety conditions associated with the use of Senvelgo (velagliflozin oral solution) for improving glycemic control in certain cats with diabetes mellitus".U.S. Food and Drug Administration. 4 December 2023. Retrieved13 December 2023.Public Domain This article incorporates text from this source, which is in thepublic domain.
Oraldiabetes medication,insulins andinsulin analogues, and other drugs used in diabetes (A10)
fast-acting
short-acting
long-acting
ultra-long-acting
inhalable
  • Exubera
  • Afrezza
Oral
Non-insulins
Insulin sensitizers
Biguanides
TZDs/"glitazones" (PPAR)
Dual PPAR agonists
Amylin analogues andDACRAs
Secretagogues
K+ATP
Sulfonylureas
Meglitinides/"glinides"
GLP-1 receptor agonists
GLP1 poly-agonist peptides
DPP-4 inhibitors/"gliptins"
Other
Aldose reductase inhibitors
Alpha-glucosidase inhibitors
SGLT2 inhibitors/"gliflozins"
Other
Combinations
SGLT1Tooltip Sodium-glucose transporter 1
SGLT2Tooltip Sodium-glucose transporter 2
SGLT1Tooltip Sodium-glucose transporter 1 &SGLT2Tooltip Sodium-glucose transporter 2


Stub icon

Thisveterinary medicine–related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Velagliflozin&oldid=1278260073"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp